Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings symbols : Mpsyf save search
MorphoSys AG Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $92.79 -0.31% 210K
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: -0.66%
H: 4.19%
C: 3.13%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 0.22%
H: 0.22%
C: -0.93%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: 0.03%
H: 1.47%
C: -0.72%
year update financial results
Incyte Reports 2023 Fourth Quarter and Year-End Financial Results, Provides 2024 Financial Guidance and Highlights R&D Priorities
Published: 2024-02-13 (Crawled : 19:00) - biospace.com/
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: 0.14%
H: 0.35%
C: 0.07%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: -3.56%
H: 2.91%
C: -3.34%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: -0.4%
H: 0.23%
C: -0.46%
MGNX | $16.14 0.25% 71K
|
Health Technology
|
| O: -5.25%
H: 2.94%
C: 2.18%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: 3.8%
H: 1.1%
C: -1.17%
financial
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
Published: 2023-11-15 (Crawled : 00:00) - biospace.com/
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: -0.38%
H: 4.02%
C: 2.88%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: -0.94%
H: 2.53%
C: -6.21%
financial results
Incyte Reports 2023 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-10-31 (Crawled : 00:00) - biospace.com/
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: 1.05%
H: 0.74%
C: 0.74%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: -0.41%
H: 2.1%
C: 1.11%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 4.23%
H: 0.12%
C: -1.97%
MGNX | $16.14 0.25% 71K
|
Health Technology
|
| O: 0.0%
H: 2.13%
C: 1.16%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: -0.39%
H: 4.09%
C: 3.8%
financial results
Incyte Reports 2023 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2023-08-01 (Crawled : 15:00) - biospace.com/
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: -2.23%
H: 2.28%
C: 1.34%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
REPL | $7.34 1.8% 74K
|
Health Technology
|
| O: 2.63%
H: 1.14%
C: -2.65%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: -0.14%
H: 4.77%
C: 4.77%
MGNX | $16.14 0.25% 71K
|
Health Technology
|
| O: 0.0%
H: 4.19%
C: 2.31%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: 2.75%
H: 0.44%
C: -2.72%
financial results
Ad hoc: MorphoSys Stops Work and Operations on Pre-Clinical Research Programs and Reduces Workforce at its Germany Headquarters
Published: 2023-03-02 (Crawled : 12:00) - biospace.com/
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: -3.1%
H: 0.92%
C: -1.14%
research pre-clinical work germany
Incyte Reports 2022 Fourth Quarter and Year-end Financial Results, Provides 2023 Financial Guidance and Updates on Key Clinical Programs
Published: 2023-02-07 (Crawled : 13:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.27%
H: 0.0%
C: 0.0%
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: -0.13%
H: 1.01%
C: 0.89%
NVS | News | $92.79 -0.31% 210K
|
Health Technology
|
| O: 0.29%
H: 0.86%
C: 0.72%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: -0.19%
H: 1.15%
C: -2.27%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 1.6%
H: 0.0%
C: -0.59%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: -1.02%
H: 0.29%
C: -3.04%
financial
MorphoSys AG Reports First Nine Months and Third Quarter 2022 Financial Results
Published: 2022-11-16 (Crawled : 23:00) - biospace.com/
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: 0.07%
H: 1.04%
C: -0.8%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: -5.85%
H: 5.41%
C: 4.32%
financial results
Incyte Reports 2022 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-11-01 (Crawled : 12:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 1.13%
H: 0.0%
C: 0.0%
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: 0.68%
H: 1.05%
C: -0.23%
NVS | News | $92.79 -0.31% 210K
|
Health Technology
|
| O: 0.47%
H: 0.09%
C: -0.55%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: 1.07%
H: 2.51%
C: -0.11%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 3.1%
H: 1.8%
C: -0.6%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: 1.59%
H: 7.26%
C: 1.89%
financial results
Incyte Reports 2022 Second Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-08-02 (Crawled : 12:00) - biospace.com/
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: -1.33%
H: 0.78%
C: -1.06%
NVS | News | $92.79 -0.31% 210K
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: -0.32%
H: 5.09%
C: 3.9%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: -3.37%
H: 3.3%
C: 0.92%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: -4.39%
H: 0.2%
C: -1.92%
results
MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
Published: 2022-07-26 (Crawled : 11:00) - biospace.com/
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: 0.07%
H: 2.75%
C: 0.83%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 0.19%
H: 5.5%
C: 4.93%
sales monjuvi
MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
Published: 2022-07-26 (Crawled : 11:00) - biospace.com/
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 0.19%
H: 5.5%
C: 4.93%
sales monjuvi
Incyte Reports 2022 First Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2022-05-03 (Crawled : 12:00) - biospace.com/
NVS | News | $92.79 -0.31% 210K
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: 2.08%
H: 1.96%
C: -0.77%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 2.45%
H: 0.92%
C: -2.03%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: 2.12%
H: 4.06%
C: 1.39%
results
MorphoSys AG Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-16 (Crawled : 22:00) - biospace.com/
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: 1.23%
H: 3.65%
C: 3.65%
RPRX | News | $27.765 0.56% 360K
|
Health Technology
|
| O: 0.42%
H: 1.77%
C: 1.48%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 1.42%
H: 7.18%
C: 4.52%
financial results report results
MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
Published: 2022-01-18 (Crawled : 11:00) - biospace.com/
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: 1.31%
H: 1.67%
C: -3.76%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: -4.31%
H: 1.1%
C: -0.73%
sales report
MorphoSys AG Reports First Nine Months and Third Quarter 2021 Results
Published: 2021-11-11 (Crawled : 10:00) - biospace.com/
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: 1.15%
H: 0.0%
C: 0.0%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -1.55%
results
MorphoSys AG Announces Monjuvi(R) Sales for the First Nine Months and Third Quarter of 2021 and Invitation to the Upcoming Conference Call on November 11, 2021
Published: 2021-11-02 (Crawled : 13:00) - biospace.com/
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
sales conference
Incyte Reports 2021 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
Published: 2021-11-02 (Crawled : 12:00) - biospace.com/
TAK | $13.2 0.38% 90K
|
Health Technology
|
| O: 0.49%
H: 0.56%
C: -0.07%
NVS | News | $92.79 -0.31% 210K
|
Health Technology
|
| O: 0.3%
H: 0.15%
C: -0.4%
XNCR | $18.94 -0.68% 23K
|
Health Technology
|
| O: 2.7%
H: 1.01%
C: 0.85%
MOR | News | $17.97 -0.39% 35K
|
Health Technology
|
| O: 3.75%
H: 1.22%
C: 1.22%
INCY | $52.63 -0.17% 170K
|
Health Technology
|
| O: -1.93%
H: 0.19%
C: -3.14%
financial results results
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
TIRX | $1.13 133.09% 44M
|
AGBA | $0.8978 124.45% 60M
|
Finance
BPTH | $6.18 90.74% 39M
|
Health Technology
INVO | $1.44 89.47% 3M
|
Health Technology
XPON | $2.66 37.82% 5.2M
|
SINT | $0.0504 35.12% 300M
|
Health Technology
THCH | $1.38 32.69% 9.9M
|
n/a
ALRN | $5.605 31.88% 210K
|
Health Technology
HOLO | $2.92 30.36% 22M
|
VTNR S | $1.25 27.66% 3.2M
|
Industrial Services
Your saved searches
Save your searches and get alerts when important news are released.